{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-007029","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2023-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.134730+00:00","generated_at":"2026-06-20T07:56:21.454171+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CVRx Q4 revenue $7.2M (+96% YoY); guides FY2023 revenue $35-38M","bullets":["Q4 2022 total revenue $7.2M, up 96% vs prior year; US HF revenue $6.0M (+121% YoY).","Full year 2022 revenue $22.5M (+72% YoY); net loss $41.4M ($2.02 per share).","Active implanting centers grew 130% to 106 in 2022 from 46 in 2021.","FY2023 guidance: revenue $35-38M, gross margin 78-79%, operating expenses $76-80M.","BeAT-HF trial unblinding and data announcement expected later in Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-007029","json":"https://secwatch.observer/filing/0001104659-23-007029.json","markdown":"https://secwatch.observer/filing/0001104659-23-007029.md","text":"https://secwatch.observer/filing/0001104659-23-007029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923007029/0001104659-23-007029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923007029/tm234419d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T07:56:21.454171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c57e72c2219e81afcf18bb10a38cb9b15683a4e5","claim":"CVRx, Inc. reported financial results for the fourth quarter and full year of 2022.","evidence_excerpt":"On January 26, 2023, CVRx, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2022. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465923007029/0001104659-23-007029-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year of 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}